Satellite Banner
Technology Networks Header
Friday, October 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Nodality Announces Publication of Promising Data in Melanoma in JTM
Friday, May 30, 2014
Nodality's SCNP platform holds strong potential in aiding the development of new cancer and immuno-oncology treatments.

Extraordinary Tools for Exceptional Results
Wednesday, May 28, 2014
New Rainin Pipet-Lite™ XLS+™ manual pipettes from Anachem.

New 20µl Liquidator 96 from Anachem
Thursday, May 22, 2014
Maximizes users workflow with fast, 96-well pipetting and no complex programming.

Next-Generation Flow Cytometry Instrument Broadens Analysis in Life Science Research
Thursday, May 22, 2014
Life Technologies Attune NxT Acoustic Focusing Cytometer expands capabilities, features modular design to fit any lab’s budget and research.

New Pipette Skins Deliver A Fun, New Way to Personalize Pipettes in the Lab
Thursday, May 22, 2014
MyPipette Skins - Easy to apply, clean and remove.

Bio-Rad Expands Portfolio of PrimePCR™ Assays for Droplet Digital™ PCR
Wednesday, May 21, 2014
Company expands its collection of validated assays for mutation detection and copy number variation.

Karolinska Institutet Utilises G:BOX Chemi XX6 in DNA Vaccine Research
Friday, May 16, 2014
Multi-application imager Makes Quantifying IR fluorescent viral antigens faster and more accurate.

Apitope Initiates Preclinical Development of Peptide Therapy, ATX-F8-117
Saturday, May 10, 2014
Peptide therapy for the treatment of Factor VIII intolerance.

Exiqon Launches Exosome Isolation Kits for Analysis of Biofluids
Thursday, May 08, 2014
miRCURY™ Exosome Isolation kits ensure exosomes recovery in less than two hours.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 1245
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv